Skip to main content
Erschienen in: International Urology and Nephrology 3/2018

01.12.2017 | Nephrology - Original Paper

Factors associated with calcium requirements after parathyroidectomy in chronic kidney disease patients

verfasst von: Yue Ding, Hongying Wang, Qiang Zou, Yiting Jin, Zijing Zhang, Junwen Huang

Erschienen in: International Urology and Nephrology | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Renal hyperparathyroidism is a common complication of chronic kidney disease (CKD). Parathyroidectomy (PTX) for these patients continues to be a valuable option in the era of calcimimetics. Postoperative hypocalcemia is common after surgery. The aim of this study was to identify clinical factors to define postoperative calcium requirements.

Methods

From February 2013 to May 2017, 68 patients with chronic kidney disease 5 (CKD5) who underwent PTX were reviewed. We collected clinical and laboratory data preoperatively and calculated the total calcium requirement in a week after surgery. Univariate and multiple analyses were performed to study whether these clinical and laboratory factors were associated with calcium requirement.

Results

Univariate analysis showed that preoperative alkaline phosphatase (ALP), calcium (Ca), parathyroid hormone and hemoglobin were independently associated with calcium requirement. Multivariate model showed that the preoperative ALP was the only independent factor that could predict the requirement of calcium.

Conclusions

In the context of a high dCa (1.75 mmol/l) and a stable dose of calcitriol, preoperative ALP levels were significantly associated with calcium requirement in patients with CKD5 undergoing PTX.
Literatur
1.
Zurück zum Zitat Levin A et al (2007) Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71(1):31–38CrossRefPubMed Levin A et al (2007) Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71(1):31–38CrossRefPubMed
2.
Zurück zum Zitat Mori K et al (2003) Acute renal failure due to adenovirus-associated obstructive uropathy and necrotizing tubulointerstitial nephritis in a bone marrow transplant recipient. Bone Marrow Transpl 31(12):1173–1176CrossRef Mori K et al (2003) Acute renal failure due to adenovirus-associated obstructive uropathy and necrotizing tubulointerstitial nephritis in a bone marrow transplant recipient. Bone Marrow Transpl 31(12):1173–1176CrossRef
3.
Zurück zum Zitat Rudofsky UH, Pollara B (1976) Studies on the pathogenesis of experimental autoimmune renal tubulointerstitial disease in guinea pigs.1 II. Passive transfer of renal lesions by anti-tubular basement membrane autoantibody and nonimmune bone marrow cells to leukocyte-depleted recipients. Clin Immunol Immunopathol 6(1):107–114CrossRefPubMed Rudofsky UH, Pollara B (1976) Studies on the pathogenesis of experimental autoimmune renal tubulointerstitial disease in guinea pigs.1 II. Passive transfer of renal lesions by anti-tubular basement membrane autoantibody and nonimmune bone marrow cells to leukocyte-depleted recipients. Clin Immunol Immunopathol 6(1):107–114CrossRefPubMed
4.
Zurück zum Zitat Lindberg JS et al (2005) Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study. J Am Soc Nephrol 16(3):800–807CrossRefPubMed Lindberg JS et al (2005) Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study. J Am Soc Nephrol 16(3):800–807CrossRefPubMed
5.
Zurück zum Zitat Palmer SC et al (2013) Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials. PLoS Med 10(4):e1001436CrossRefPubMedPubMedCentral Palmer SC et al (2013) Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials. PLoS Med 10(4):e1001436CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Narayan R et al (2007) Parathyroidectomy versus cinacalcet hydrochloride-based medical therapy in the management of hyperparathyroidism in ESRD: a cost utility analysis. Am J Kidney Dis 49(6):801–813CrossRefPubMed Narayan R et al (2007) Parathyroidectomy versus cinacalcet hydrochloride-based medical therapy in the management of hyperparathyroidism in ESRD: a cost utility analysis. Am J Kidney Dis 49(6):801–813CrossRefPubMed
7.
Zurück zum Zitat Torer N et al (2009) Predictors of early postoperative hypocalcemia in hemodialysis patients with secondary hyperparathyroidism. Transplant Proc 41(9):3642–3646CrossRefPubMed Torer N et al (2009) Predictors of early postoperative hypocalcemia in hemodialysis patients with secondary hyperparathyroidism. Transplant Proc 41(9):3642–3646CrossRefPubMed
8.
Zurück zum Zitat Strickland PL, Recabaren J (2002) Are preoperative serum calcium, parathyroid hormone, and adenoma weight predictive of postoperative hypocalcemia? Am Surg 68(12):1080–1082PubMed Strickland PL, Recabaren J (2002) Are preoperative serum calcium, parathyroid hormone, and adenoma weight predictive of postoperative hypocalcemia? Am Surg 68(12):1080–1082PubMed
9.
Zurück zum Zitat Mittendorf EA, Merlino JI, McHenry CR (2004) Post-parathyroidectomy hypocalcemia: incidence, risk factors, and management. Am Surg 70(2):114–119 (discussion 119–120) PubMed Mittendorf EA, Merlino JI, McHenry CR (2004) Post-parathyroidectomy hypocalcemia: incidence, risk factors, and management. Am Surg 70(2):114–119 (discussion 119–120) PubMed
10.
Zurück zum Zitat Kang BH et al (2015) Predicting postoperative total calcium requirements after parathyroidectomy in secondary hyperparathyroidism. Korean J Intern Med 30(6):856–864CrossRefPubMedPubMedCentral Kang BH et al (2015) Predicting postoperative total calcium requirements after parathyroidectomy in secondary hyperparathyroidism. Korean J Intern Med 30(6):856–864CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Goh BL, Yudisthra MG, Hisham AN (2010) Alkaline phosphatase predicts calcium requirements after total parathyroidectomy in patients receiving dialysis. Br J Surg 97(2):185–188CrossRefPubMed Goh BL, Yudisthra MG, Hisham AN (2010) Alkaline phosphatase predicts calcium requirements after total parathyroidectomy in patients receiving dialysis. Br J Surg 97(2):185–188CrossRefPubMed
12.
Zurück zum Zitat National Kidney F (2003) K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42(4 Suppl 3):S1–S201 National Kidney F (2003) K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42(4 Suppl 3):S1–S201
13.
Zurück zum Zitat Coburn JW et al (1973) Study of intestinal absorption of calcium in patients with renal failure. Kidney Int 3(4):264–272CrossRefPubMed Coburn JW et al (1973) Study of intestinal absorption of calcium in patients with renal failure. Kidney Int 3(4):264–272CrossRefPubMed
14.
Zurück zum Zitat Goodman WG et al (2000) Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342(20):1478–1483CrossRefPubMed Goodman WG et al (2000) Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342(20):1478–1483CrossRefPubMed
15.
Zurück zum Zitat Raggi P et al (2002) Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 39(4):695–701CrossRefPubMed Raggi P et al (2002) Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 39(4):695–701CrossRefPubMed
16.
Zurück zum Zitat Lewin E, Wang W, Olgaard K (1997) Reversibility of experimental secondary hyperparathyroidism. Kidney Int 52(5):1232–1241CrossRefPubMed Lewin E, Wang W, Olgaard K (1997) Reversibility of experimental secondary hyperparathyroidism. Kidney Int 52(5):1232–1241CrossRefPubMed
17.
Zurück zum Zitat Urena P et al (2009) Cinacalcet and achievement of the NKF/K-DOQI recommended target values for bone and mineral metabolism in real-world clinical practice—the ECHO observational study. Nephrol Dial Transplant 24(9):2852–2859CrossRefPubMed Urena P et al (2009) Cinacalcet and achievement of the NKF/K-DOQI recommended target values for bone and mineral metabolism in real-world clinical practice—the ECHO observational study. Nephrol Dial Transplant 24(9):2852–2859CrossRefPubMed
18.
Zurück zum Zitat Schneider R et al (2010) An economic comparison of surgical and medical therapy in patients with secondary hyperparathyroidism—the German perspective. Surgery 148(6):1091–1099CrossRefPubMed Schneider R et al (2010) An economic comparison of surgical and medical therapy in patients with secondary hyperparathyroidism—the German perspective. Surgery 148(6):1091–1099CrossRefPubMed
19.
Zurück zum Zitat Ghani A, Baxter P (2012) Surgical parathyroidectomy versus cinacalcet therapy: in the management of secondary hyperparathyroidism. Otolaryngol Head Neck Surg 146(2):220–225CrossRefPubMed Ghani A, Baxter P (2012) Surgical parathyroidectomy versus cinacalcet therapy: in the management of secondary hyperparathyroidism. Otolaryngol Head Neck Surg 146(2):220–225CrossRefPubMed
20.
Zurück zum Zitat Brasier AR, Nussbaum SR (1988) Hungry bone syndrome: clinical and biochemical predictors of its occurrence after parathyroid surgery. Am J Med 84(4):654–660CrossRefPubMed Brasier AR, Nussbaum SR (1988) Hungry bone syndrome: clinical and biochemical predictors of its occurrence after parathyroid surgery. Am J Med 84(4):654–660CrossRefPubMed
21.
Zurück zum Zitat Cruz DN, Perazella MA (1997) Biochemical aberrations in a dialysis patient following parathyroidectomy. Am J Kidney Dis 29(5):759–762CrossRefPubMed Cruz DN, Perazella MA (1997) Biochemical aberrations in a dialysis patient following parathyroidectomy. Am J Kidney Dis 29(5):759–762CrossRefPubMed
23.
Zurück zum Zitat Araya V, Oviedo S, Amat J (2000) Hungry bone syndrome: clinical experience in its diagnosis and treatment. Rev Med Chil 128(1):80–85CrossRefPubMed Araya V, Oviedo S, Amat J (2000) Hungry bone syndrome: clinical experience in its diagnosis and treatment. Rev Med Chil 128(1):80–85CrossRefPubMed
24.
25.
Zurück zum Zitat Ho LY et al (2017) Risk factors and clinical course of hungry bone syndrome after total parathyroidectomy in dialysis patients with secondary hyperparathyroidism. BMC Nephrol 18(1):12CrossRefPubMedPubMedCentral Ho LY et al (2017) Risk factors and clinical course of hungry bone syndrome after total parathyroidectomy in dialysis patients with secondary hyperparathyroidism. BMC Nephrol 18(1):12CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Tsai WC et al (2015) Risk factors for severe hypocalcemia after parathyroidectomy in prevalent dialysis patients with secondary hyperparathyroidism. Int Urol Nephrol 47(7):1203–1207CrossRefPubMed Tsai WC et al (2015) Risk factors for severe hypocalcemia after parathyroidectomy in prevalent dialysis patients with secondary hyperparathyroidism. Int Urol Nephrol 47(7):1203–1207CrossRefPubMed
27.
Zurück zum Zitat Guo CY et al (2000) Immediate changes in biochemical markers of bone turnover and circulating interleukin-6 after parathyroidectomy for primary hyperparathyroidism. Eur J Endocrinol 142(5):451–459CrossRefPubMed Guo CY et al (2000) Immediate changes in biochemical markers of bone turnover and circulating interleukin-6 after parathyroidectomy for primary hyperparathyroidism. Eur J Endocrinol 142(5):451–459CrossRefPubMed
28.
Zurück zum Zitat Sun L, He X, Liu T (2014) Preoperative serum alkaline phosphatase: a predictive factor for early hypocalcaemia following parathyroidectomy of primary hyperparathyroidism. Chin Med J (Engl) 127(18):3259–3264 Sun L, He X, Liu T (2014) Preoperative serum alkaline phosphatase: a predictive factor for early hypocalcaemia following parathyroidectomy of primary hyperparathyroidism. Chin Med J (Engl) 127(18):3259–3264
29.
Zurück zum Zitat Gal-Moscovici A, Popovtzer MM (2005) New worldwide trends in presentation of renal osteodystrophy and its relationship to parathyroid hormone levels. Clin Nephrol 63(4):284–289CrossRefPubMed Gal-Moscovici A, Popovtzer MM (2005) New worldwide trends in presentation of renal osteodystrophy and its relationship to parathyroid hormone levels. Clin Nephrol 63(4):284–289CrossRefPubMed
Metadaten
Titel
Factors associated with calcium requirements after parathyroidectomy in chronic kidney disease patients
verfasst von
Yue Ding
Hongying Wang
Qiang Zou
Yiting Jin
Zijing Zhang
Junwen Huang
Publikationsdatum
01.12.2017
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 3/2018
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-017-1759-8

Weitere Artikel der Ausgabe 3/2018

International Urology and Nephrology 3/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.